Atlas FDA

TAP SYSTEM 2A

FDA premarket approval P840002/S013 · decided 2016-03-24

Approval details

PMA number
P840002
Supplement
S013
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
TAP SYSTEM 2A
Generic name
SYSTEM, ESOPHAGEAL PACING
Applicant
Cardiocommand, Inc.
Date received
2015-05-28
Decision date
2016-03-24
Days to decision
301 days
Decision code
APPR
Product code
LPA
Advisory committee
Cardiovascular
Expedited review
No
Location
Tampa, FL
Statement
Approval for a manufacturing site located at Cardiocommand, Inc., in Tampa, Florida, for the manufacture of the Tapsystem Model 2A device.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.